Accurate risk assessment of central nervous system diseases such as Alzheimer's disease (AD), cerebral apoplexy, and white matter hyperintensities
Cutting-edge technologies
Comprehensive brain structure exam
Highly efficient and automated
Highly accurate
Artificial intelligence identifies subtle brain structural lesions that are difficult to detect with the naked eye, significantly advancing disease screening and diagnostic windows
One click generation of structured reports for more intuitive presentation of results
AI combines big data to establish disease risk prediction models, assisting clinical decision-making with more accurate judgments
Requiring FLAIR sequence scanning only, free of hardware platform and network limitations
Fully automated and able to finish analysis within 1 minute
Segmenting lesions accurately to generate Fazekas scores
Automatically generating structured reports with visualized indicator data
